Electromed Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Electromed Stock Summary

Electromed competes with Neuropace, Orthopediatrics Corp, SurModics, Paragon 28, and LivaNova PLC. Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of various ages in the United States and internationally. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota. Electromed operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 156 people.

Electromed Key Financial Ratios

Electromed Key Balance Sheet Accounts

Electromed Key Income Statement Accounts

Electromed Key Cash Accounts

Electromed Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Electromed's current stock value. Our valuation model uses many indicators to compare Electromed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Electromed competition to find correlations between indicators driving Electromed's intrinsic value. More Info.Electromed is rated # 3 in return on equity category among its peers. It is rated # 2 in return on asset category among its peers reporting about  0.67  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Electromed is roughly  1.49 . At present, Electromed's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Electromed by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Electromed Systematic Risk

Today, most investors in Electromed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Electromed's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Electromed growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Electromed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Electromed. We use our internally-developed statistical techniques to arrive at the intrinsic value of Electromed based on widely used predictive technical indicators. In general, we focus on analyzing Electromed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Electromed's daily price indicators and compare them against related drivers.

When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.